Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Database
Publication year range
1.
Zhonghua Gan Zang Bing Za Zhi ; 32(6): 504-507, 2024 Jun 20.
Article in Chinese | MEDLINE | ID: mdl-38964892

ABSTRACT

Non-alcoholic fatty liver disease (NAFLD) is a common concomitant disease in adults with type 2 diabetes mellitus (T2DM) and prediabetes. Therefore, T2DM/NAFLD patient populations are at high risk for cardiovascular disease. The occurrence and progression of non-alcoholic fatty liver disease-related liver fibrosis and cardiovascular disease have a severe impact on the patient's prognosis and mortality rate. The American Diabetes Association's 2024 "Guidelines for the Standardized Management of Diabetes" put forward recommendations relevant to the screening, evaluation, treatment, and management of NAFLD in T2DM and prediabetic populations, as well as liver fibrosis. The important measures for decelerating liver inflammation and fibrosis progression and the risk of cardiovascular disease are based on improvements in lifestyle methods, weight loss, and blood sugar control.


Subject(s)
Diabetes Mellitus, Type 2 , Non-alcoholic Fatty Liver Disease , Non-alcoholic Fatty Liver Disease/therapy , Non-alcoholic Fatty Liver Disease/complications , Non-alcoholic Fatty Liver Disease/diagnosis , Humans , Diabetes Mellitus, Type 2/complications , Diabetes Mellitus, Type 2/therapy , United States , Prediabetic State/therapy , Prediabetic State/diagnosis , Prediabetic State/complications , Cardiovascular Diseases/prevention & control , Cardiovascular Diseases/etiology , Cardiovascular Diseases/therapy , Liver Cirrhosis/complications , Liver Cirrhosis/therapy , Liver Cirrhosis/diagnosis
3.
Zhonghua Nei Ke Za Zhi ; 60(10): 904-907, 2021 Oct 01.
Article in Chinese | MEDLINE | ID: mdl-34551480

ABSTRACT

To investigate the effectiveness and safety of ultrasound-guided microwave ablation (MWA) in treatment of primary hyperparathyroidism (PHPT). A total of 12 PHPT patients with parathyroid adenoma were treated with MWA in Nanjing University of Chinese Medicine Affiliated Hospital of Integrated Traditional Chinese and Western Medicine from May 2019 to February 2021. The patients were followed up once every 3 months for 3-12 months. Levels of serum parathyroid hormone (PTH), calcium and phosphorus were detected before and 20 min, 4h and 1day after ablation, and during follow-up period. The volume and volume reduction rate of parathyroid lesion were compared before the treatment and at the end of follow-up. The technical and clinical success of MWA were assessed as well. At the end of follow-up, median serum PTH [66.60 (42.21,80.03) ng/L vs.169.90 (89.01,396.50) ng/L] and calcium [2.39 (2.32,2.49) mmol/L vs. 2.75 (2.57,2.96) mmol/L] levels in 12 patients decreased significantly (all P<0.05). A complete response in terms of PTH and calcium levels was achieved in 6 of the 12 patients, while 4 of the patients had slightly elevated PTH levels just above the upper limit of normal reference range, and 2 of the patients remained abnormal PTH and calcium levels. The clinical cure rate was 50%. The volumes of all lesion after ablation were significantly decreased (P<0.05), with the technical success rate reaching 92.3%. No serious complications were observed. Ultrasound-guided MWA, thus, is safe and effective in the treatment of PHPT.


Subject(s)
Hyperparathyroidism, Primary , Parathyroid Neoplasms , Radiofrequency Ablation , Calcium , Humans , Hyperparathyroidism, Primary/diagnostic imaging , Hyperparathyroidism, Primary/surgery , Microwaves/therapeutic use , Parathyroid Hormone , Parathyroid Neoplasms/complications , Parathyroid Neoplasms/diagnostic imaging , Parathyroid Neoplasms/surgery , Ultrasonography, Interventional
4.
Zhonghua Zhong Liu Za Zhi ; 41(6): 415-420, 2019 Jun 23.
Article in Chinese | MEDLINE | ID: mdl-31216826

ABSTRACT

Objective: To evaluate the tolerability and short-term efficacy of chemo-radiotherapy in 125 patients with stage ⅡB-ⅣA esophageal carcinoma after radical resection. Methods: We retrospectively evaluated the rate of completion, toxicity and survival of patients undergoing adjuvant concurrent chemo-radiotherapy after radical resection of esophageal carcinoma from January 2004 to December 2014 in our institution. The survival rate was determined by the Kaplan-Meier method and analyzed using the log-rank test. Multivariate prognostic analysis was performed using the Cox proportional hazard model. Results: 122 patients received more than 50 Gy dose (97.6%). A total of 52 patients received more than 5 weeks chemo-radiotherapy (41.6%), while 73 patients underwent only 1-4 weeks (58.4%). The median following up was 48.4 months. 8 patients lost follow up (6.4%). The 1-year and 3-year overall survival rate were 91.6% and 57.0%, respectively, with a median survival time of 64.4 months. The 1-year and 3-year disease free survival rate were 73.2% and 54.3%, respectively, with a median disease free survival time of 59.1 months. The most common acute complications associated with chemo-radiotherapy were myelosuppression, radiation esophagitis and radiation dermatitis, the majority of which were Grade 1-2. Of the 125 patients, there were 59 cases of recurrence, including 23 cases with local regional recurrence, 26 cases with hematogenous metastasis, and 8 cases with mixed recurrence. Univariate analysis showed that the numbers of concurrent chemotherapy was associated with the overall survival (P=0.006). But receiving more than 5 weeks was not the prognostic factor compared to 1 to 4 weeks chemotherapy (P=0.231). Multivariate analysis showed that only the numbers of concurrent chemotherapy was an independent prognostic factor (P=0.010). Conclusions: Postoperative radiotherapy concurrent with weekly chemotherapy could improve the overall survival and decrease the recurrence for stage ⅡB-ⅣA esophageal carcinoma after radical resection. However, the completion rate of chemotherapy was low, so it was necessary to explore reasonable regimens to improve the completion rate and carry out prospective randomized controlled trial.


Subject(s)
Carcinoma/drug therapy , Carcinoma/radiotherapy , Chemotherapy, Adjuvant/adverse effects , Esophageal Neoplasms/drug therapy , Esophageal Neoplasms/radiotherapy , Radiotherapy, Adjuvant/adverse effects , Carcinoma/surgery , Chemotherapy, Adjuvant/methods , Combined Modality Therapy/adverse effects , Esophageal Neoplasms/surgery , Humans , Neoplasm Staging , Retrospective Studies , Treatment Outcome
5.
Zhonghua Zhong Liu Za Zhi ; 41(4): 295-302, 2019 Apr 23.
Article in Chinese | MEDLINE | ID: mdl-31014056

ABSTRACT

Objective: The role of planned neoadjuvant radiotherapy or chemoradiotherapy in the non-radical resection of esophageal squamous cell carcinoma was unclear. The study aimed to evaluate their therapeutic effect and analyze the prognostic factors. Methods: We retrospectively analyzed the clinical data of locally advanced esophageal squamous cell carcinoma who received neoadjuvant radio therapy (33 patients) and concurrent chemoradiotherapy (119 patients) from January 2004 to December 2016 in our single-institution database.The survival rates were calculated by Kaplan-Meier method. The prognostic factors were analyzed by using Log rank test and Cox proportional hazards model. Results: The median follow-up was 29.8 months. One hundred and one patients survived more than 3 years. The rates of overall survival (OS) and disease-free survival (DFS) at 3 years were 63.9% and 55.6%, respectively.The rates of complete, partial and minimal pathological response of the primary tumor were 50.3%, 38.4%, 11.3%, the corresponding 3-year OS were 75.5%, 57.4%, 27.3% (P<0.001) and 3-year DFS were 72.0%, 44.7%, 17.6% (P<0.001), respectively.The postoperative lymph node metastasis rate was 27.0%. The 3-year OS and DFS of the lymph node positive group was 45.6% and 32.8%, significantly lower than 70.8% and 63.7% of the negative group (both P<0.001). The 3-year OS and DFS of pathologic stage Ⅰ, Ⅱ, ⅢA, ⅢB and Ⅵ A were 76.2%, 57.4%, 64.7%, 35.0%, 33.3% (P<0.001) and 70.1%, 49.3%, 41.2%, 22.1%, 33.3% (P<0.001), respectively.The operation-related mortality was 3.3%. Multivariate analysis showed that chest pain, postoperative respiratory failure, pathological differentiation, more than 15 lymph node dissection and ypTNM stage were the independent prognostic factors of OS (P<0.05 for all). Conclusions: The planned neoadjuvant radiotherapy or chemoradiotherapy for the non-radical resection of advanced esophageal squamous cell carcinoma could result in favorable survival. The chest pain, postoperative respiratory failure, pathological differentiation, the number of lymph node resection and ypTNM stage are the independent prognostic factors of the prognosis of these patients.


Subject(s)
Chemoradiotherapy , Esophageal Neoplasms/therapy , Esophageal Squamous Cell Carcinoma/therapy , Esophageal Neoplasms/mortality , Esophageal Neoplasms/radiotherapy , Esophageal Squamous Cell Carcinoma/mortality , Esophageal Squamous Cell Carcinoma/radiotherapy , Humans , Kaplan-Meier Estimate , Neoadjuvant Therapy , Neoplasm Staging , Prognosis , Radiotherapy, Adjuvant , Retrospective Studies , Survival Rate
6.
Opt Express ; 26(17): 22064-22074, 2018 Aug 20.
Article in English | MEDLINE | ID: mdl-30130906

ABSTRACT

In this work, we investigate the Fourier characteristics of wavelength-scanned optical spectrum of low-finesse Fabry-Pérot (FP) acoustic sensor both theoretically and experimentally. The wavelength scanning will transform the time-domain acoustic signal into phase modulation loaded on the FP sensor spectrum distributed along wavelength. Therefore the interference spectrum can be regarded as carrier signal in the wavelength domain. From this perspective, it is intelligible that the phase modulation loaded on the spectrum (carrier signal) will introduce sidebands in Fourier domain. The spatial frequency and phase of sideband components contain unique information of both acoustic signal and the corresponding sensor. These conclusions are experimentally proved by single sensor head as well as two parallel sensors. The Fourier characteristics of sideband components can be utilized to recognize and distinguish acoustic signals received by different sensors, indicating that it has potential applications in multiplexed FP sensor array and source localization, and so forth.

7.
Cell Mol Biol (Noisy-le-grand) ; 62(11): 95-99, 2016 Sep 30.
Article in English | MEDLINE | ID: mdl-27755959

ABSTRACT

Renal ischemia/reperfusion (I/R) damage may arise due to nephron sparing surgery in patient with a solitary kidney of restricted renal parenchymas. Apoptosis, inflammation and oxidative stress play a significant role in the expansion of renal dysfunction following renal I/R. The aim of the current investigation was to particularize the potential effect of curcumin against hypoxia induced renal injury. The albino Wistar rats divided into groups and each group contains six rats. They groups are normal control; disease control; curcumin (5 mg/kg per day) and another group orally treated with curcumin (10 mg/kg per day) for two weeks before induction of renal I/R. The renal and serum samples were collected and used for the biochemical estimation. The renal tissue was further used for the histopathological estimation. The result of the current investigation demonstrated that the curcumin significantly (P<0.01) attenuated I/R induced renal injury in a dose-dependent way. It also causes significant (P<0.01) reduction in the serum creatinine, blood urea nitrogen level and also suppressed the kidney injury molecules-1. Additionally, it also causes significant inhibition of the malonaldehyde, caspase-3, myeloperoxide, lactose dehydrogenase and interferon-gamma together with enhanced interlukin-10 content.


Subject(s)
Curcumin/pharmacology , Inflammation Mediators/metabolism , Kidney/drug effects , Protective Agents/pharmacology , Animals , Antioxidants/metabolism , Blood Urea Nitrogen , Caspase 3/metabolism , Caspase Inhibitors/pharmacology , Cell Adhesion Molecules/metabolism , Creatinine/blood , Curcumin/therapeutic use , Disease Models, Animal , Kidney/metabolism , Kidney/pathology , Kidney Function Tests , Lactose/analogs & derivatives , Lactose/metabolism , Male , Protective Agents/therapeutic use , Rats , Rats, Wistar , Reperfusion Injury/metabolism , Reperfusion Injury/pathology , Reperfusion Injury/prevention & control
8.
Immunol Invest ; 44(6): 521-35, 2015.
Article in English | MEDLINE | ID: mdl-26207789

ABSTRACT

Total glucoside of paeony (TGP), extracted from the root of Paeonia Lactiflora, has been known to show anti-inflammatory, anti-oxidative, hepato-protective and immuno-regulatory activities. The aim of this present study was to determine the anti-tumor effect of TGP against N-nitrosodiethylamine (DEN)-induced hepatocellular carcinoma (HCC) in rats, and to find the related mechanisms. Rat HCC model was established by intragastrically administrating with DEN (8 mg/kg). We found the number of tumor nodules and the index of liver and spleen were increased in the model group compared with the normal group, and was significantly decreased by TGP. Additionally, TGP obviously improved the hepatic pathological lesions induced by DEN, and decreased the elevated levels of serum alanine aminotransferase (ALT), glutamic oxalacetic transaminase (AST), alkaline phosphatase (ALP) and alpha fetoprotein (AFP) by DEN. Moreover, TGP decreased the level of B cell-activating factor (BAFF) and the proportion of IL-10-producing regulatory B cells (Bregs), and the decrease of BAFF by TGP is positively correlated to the decrease of IL-10-producing Bregs by TGP. These results suggest that TGP had a good therapeutic action on DEN-induced HCC rats, which might be due to its down-regulation of Bregs through reducing the level of BAFF.


Subject(s)
Antineoplastic Agents, Phytogenic/therapeutic use , B-Lymphocytes, Regulatory/drug effects , Carcinoma, Hepatocellular/drug therapy , Glucosides/therapeutic use , Liver Neoplasms, Experimental/drug therapy , Paeonia , Alanine Transaminase/blood , Alkaline Phosphatase/blood , Animals , Antineoplastic Agents, Phytogenic/pharmacology , Aspartate Aminotransferases/blood , B-Cell Activating Factor/blood , B-Lymphocytes, Regulatory/immunology , Carcinoma, Hepatocellular/chemically induced , Carcinoma, Hepatocellular/immunology , Carcinoma, Hepatocellular/pathology , Diethylnitrosamine , Down-Regulation , Glucosides/pharmacology , Interleukin-10/immunology , Liver Neoplasms, Experimental/chemically induced , Liver Neoplasms, Experimental/immunology , Liver Neoplasms, Experimental/pathology , Male , Phytotherapy , Rats, Sprague-Dawley
9.
Neuroreport ; 11(16): 3439-41, 2000 Nov 09.
Article in English | MEDLINE | ID: mdl-11095495

ABSTRACT

Ciliary neurotrophic factor (CNTF) acts through the JAK/STAT signal transduction pathway. However, the rapid action of CNTF cannot readily be explained by reference to this pathway. Using the fluorophore, Fura 2-AM, and fluorescence imaging, the effect of CNTF on glutamate-induced increases in hippocampal intraneuronal free Ca2+ ([Ca2+]i) was investigated. Glutamate induces a rapid increase in [Ca2+]i. Incubation of hippocampal neurons with CNTF for 5 min inhibited the glutamate-induced increase in [Ca2+]i. In the absence of glutamate, CNTF had no effect on [Ca2+]i. Pertussis toxin (PTX), a G-protein antagonist, partially blocked the effect of CNTF. This suggests that CNTF may act via an alternative signal transduction pathway besides the generic JAK/STAT pathway.


Subject(s)
Calcium/metabolism , Ciliary Neurotrophic Factor/pharmacology , Glutamic Acid/pharmacology , Hippocampus/physiology , Neurons/physiology , Animals , Animals, Newborn , Cells, Cultured , Intracellular Fluid/drug effects , Intracellular Fluid/physiology , Kinetics , Neurons/cytology , Neurons/drug effects , Pertussis Toxin , Rats , Rats, Sprague-Dawley , Signal Transduction/drug effects , Signal Transduction/physiology , Virulence Factors, Bordetella/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...